Product Description
The vaginal suppository is used for the reduction and/or inhibition of vaginal biofilms that were shown to be related to recurrent bacterial vaginosis. (Sourced from: https://clinicaltrials.gov/ct2/show/study/NCT02687789)
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: N/A
Route of Administration: Vaginal
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Dr. August Wolff & KG Arzneimittel
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| WOAF-11/2012 | N/A |
Completed |
Vaginosis, Bacterial|Vaginal Diseases |
2015-07-01 |